false
Catalog
Clinical Data on Rhythm Control Strategies and Imp ...
Recent clinical data on rhythm control strategies ...
Recent clinical data on rhythm control strategies and implications for patient care
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Paulus Gerjof discusses recent clinical data on rhythm control strategies for atrial fibrillation (AF). He highlights that even with optimal anticoagulation and background therapy, there is still a measurable rate of stroke, cardiovascular death, and heart failure hospitalizations in AF patients. The EAST-AF 412 trial tested whether early rhythm control therapy, incorporating antiarrhythmic drugs, could reduce these outcomes. The trial found that early rhythm control therapy reduced cardiovascular events by 21% over five years. The therapy was delivered mainly through antiarrhythmic drugs. The findings suggest that early rhythm control therapy should be considered the default strategy for most AF patients, especially the elderly and those with multiple comorbidities.
Keywords
rhythm control strategies
atrial fibrillation
clinical data
anticoagulation
cardiovascular events
×
Please select your language
1
English